Differential expression of major histocompatibility complex class Ia, Ib and II molecules on monocytes and monocyte-derived dendritic and macrophagic cells

Human Immunology

Volumn 60, Issue 7, 1999, Pages 591-597

  Laupeze B ^a   Fardel, O ^b   Onno, M ^a   Bertho, N ^a   Drenou B ^a   Fauchet, R ^a   Amiot, L ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

^b INSERM   (France)

Author keywords

Dendritic cells; HLA G; Macrophages; MHC; Quantification

Indexed keywords

COLONY STIMULATING FACTOR 1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOTHERAPY; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MONOCYTE; PRIORITY JOURNAL;

EID: 17344375965     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(99)00025-7     Document Type: Article

References (22)

1. Derek N., Hart J. Dendritic cells unique leukocyte populations which control the primary immune response . Blood. 90:1997;3245.
2. Abbas AK, Lichtman AH., Pober JS: Antigen processing and presentation to T lymphocytes. In Sauders W.B. Company (eds), 1997: cellular and molecular immunology, Philadelphia, PA, 1997.
3. Lee N., Malacko A.R., Ishitani A., Chen M.C., Bajorath J., Marquardt H., Geraghty D. The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity. 3:1995;591.
4. 1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc Natl Acad Sci USA. 94:1997;5249.
5. Lee N., Llano M., Carretero M., Ishitani A., Navarro F., Lopez-Botet M., Geraghty D.E. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2a. Proc Natl Sci USA. 95:1998;5199.
6. Amiot L., Onno M., Drénou B., Monvoisin C., Fauchet R. HLA-G class I gene expression in normal and malignant hematopoietic cells. Hum Immunol. 59:1998;524.
7. Cohen P.J., Cohen P.A., Rosenberg S.A., Katz S.I., Mule J.J. Murine epidermal Langherans cells and splenic dendritic cells present tumor-associated antigens to primed T cells. Eur J Imunol. 24:1994;31.
8. Hsu F.J., Benike C., Fagnoni F., Liles T.M., Czerwinski D., Taidi B., Engleman E.G., Levy R. Vaccination of patients with B cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med. 2:1996;52.
9. Hennemann B., Beckmann G., Eichelmann A., Rehm A., Andreesen R. Phase I trial of adoptive immunotherapy of cancer patients using monocyte-derived macrophages activated with interferon gamma and lipopolysaccharide. Cancer Immunol Immunother. 45:1998;250.
10. Celluzzi C.M., Mayordomo J.I., Storkus W.J., Lotze M.T., Falo L.D. Peptide pulsed dendritic cells induce antigen specific CTL mediated protective tumor immunity. J Exp Med. 183:1996;283.
11. Nestle F.O., Alijagic S., Gilliet M., Sun Y., Grabbe S., Dummer R., Burg G., Schadendorf D. Vaccination of melanoma patients with peptide or tumor lysate-pulsate dendritic cells. Nat Med. 4:1998;328.
12. Bernhard H., Disis M.L., Heimfeld S., Hand S., Gralow J.R., Cheever M.A. Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood. Cancer Res. 55:1995;1099.
13. Chapuis F., Rosenzwajg M., Yagello M., Ekman M., Biberfeld P., Gluckman J.C. Differentiation of human dendritic cells from monocytes in vitro. Eur J Immunol. 27:1997;434.
14. Romani N., Gruner S., Brang D., Kämpgen E., Lenz A., Trockenbacher B., Konwalinka G., Fritsch P.O., Steiman R.M., Schuler G. Proliferating dendritic cell progenitors in human blood. J Exp Med. 180:1994;83.
15. Poncelet P., Carayon P. Cytofluorometric quantification of cell surface antigens by indirect immunofluorescence using monoclonal antibodies. J Immunol Methods. 85:1985;65.
16. Burt D., Johnston D., Rinke de Wit T., Van den Elsen P., Stern P.L. Cellular immune recognition of HLA-G expressing choriocarcinoma cell line Jeg3. Int J Cancer. 6:1991;117.
17. Freudenthal P.S., Steiman R.M. The distinct surface of human blood dendritic cells, as observed after an improved isolation method. Proc Natl Acad Sci USA. 87:1990;7698.
18. Toujas L., Delcros J.G., Diez E., Gervois N., Semana G., Corradin G., Jotereau F. Human monocyte-derived macrophages and dendritic cells are comparably effective in vitro in presenting HLA class I restricted exogenous peptides. Imunol. 91:1997;635.
19. Brossart P., Bewan M.J. Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines. Blood. 90:1997;1594-1599.
20. Mehta-Damani A., Markowicz S., Engleman E.G. Generation of antigen specific CD8+ CTLs from naive precursors. J Immunol. 153:1994;996.
21. Van den Elsen P.J., Peijnenburg A.D., Van Eggermond M.C.J.A., Gobin S.J.P. Shared regulatory elements in the promoters of MHC class I and class II genes. Immunol Today. 19:1998;308.
22. Yi-lu L., Benveniste E.N. Stat1 expression is involved in IFN induction of the class II transactivator and class II MHC genes. J Immunol. 157:1996;1559.